INVESTIGATING SAFETY AND PRELIMINARY EFFICACY OF AFM13 PLUS PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA AFTER BRENTUXIMAB VEDOTIN FAILURE

Overview of attention for article published in Hematological Oncology, June 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 7 X users

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 10 X posts from 7 X users, with an upper bound of 6,843 followers.

https://t.co/0PVcffxLgZ

RT @8thKingofRome: $AFMD Investigating Safety And Preliminary Efficacy Of Afm13 Plus Pembrolizumab In Patients With Relapsed/Refractory Hod…

RT @8thKingofRome: $AFMD Longer term follow up results will be presented at the meeting (Saturday, June 22). https://t.co/qRdd21lGa3

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 6 additional X posts.